Document is current
Any future updates will be listed below
-
Authors
Koychev, Ivan http://orcid.org/0000-0001-6813-8493
Reid, Graham http://orcid.org/0000-0002-6079-9323
Nguyen, Maggie
Mentz, Robert J.
Joyce, Dan
Shah, Svati H.
Holman, Rury R.
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 9 September 2024
First Online: 2 October 2024
Declarations
:
: All the patients provided written informed consent in accordance with the Declaration of Helsinki. The study was approved in the UK by Scotland A Research Ethics Committee (reference 11/AL/0042) on 12th of April 2011 and subsequently by ethics committees at each study site.
: Not applicable.
: IK received research support and honoraria from Novo Nordisk. He is a paid medical advisor for biotechnology (cfdx Ltd) and digital healthcare companies working in dementia (Five Lives SAS, Cognetivity, Mantrah Ltd). RJM received research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Eli Lilly, Medtronic, Medable, Merck, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Relypsa, Respicardia, Roche, Rocket Pharmaceuticals, Sanofi, Verily, Vifor, Windtree Therapeutics, and Zoll. RRH reports personal fees from Anji Pharmaceuticals, AstraZeneca, and Novartis.
